BWA
IDXX icon

Basecamp Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Basecamp Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439K Hold
833
– – 0.08% 138
2026
Q1 		$468K Hold
833
– – 0.1% 128
2025
Q4 		$564K Buy
+833
New +$567K 0.12% 102

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Basecamp Wealth Advisors's IDXX Position: Q2 2026 in Review

Basecamp Wealth Advisors held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 833 shares worth $439K. The position accounts for 0.08% of the portfolio, ranked #138.

Basecamp Wealth Advisors first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $564K in Q4 2025. 1,290 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Basecamp Wealth Advisors held 833 shares of Idexx Laboratories worth $439K as of Q2 2026.
  • Basecamp Wealth Advisors left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.08% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #138 holding.
  • Basecamp Wealth Advisors first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Idexx Laboratories position peaked at $564K in Q4 2025.
  • 1,290 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.